Cannabis Law Report

FEBRUARY 26, 2022

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. The analysis explores barriers to access, civil protections, affordability, health and social equity, and product safety, as well as penalties for detrimental policies. ASA examines medical cannabis law efficacy.

Access 98

Access Law Patients Programs 98

NewsMunchies

JULY 30, 2018

Lawmakers baselessly argued that smoking as a method for medical treatment would be a “backdoor attempt” at allowing recreational use. First, they cannot legally access the treatment recommended for them,” Gievers opined in the four-page ruling. This could certainly affect the inventory supply chain for some patients.

Marijuana 47

Marijuana Supply Chain Patients Edibles 47

Cannabis Law Report

MARCH 25, 2020

(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM ® Biotechnologies, Inc. CEO Dr. Stuart Titus.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Clinical Trials 59

Cannabis Law Report

MAY 12, 2022

To further prevent and reduce drug harm in our communities, we have made changes to ensure a more sensible medical cannabis regime, and taken a safety-first approach to drugs at festivals. We have also ensured more drug and alcohol treatment and support is available for those who need it. RICKY WILSON/STUFF.

Supply Chain 52

Supply Chain Cannabis Topical Education 52

SpeedWeed

AUGUST 2, 2021

This evaluation includes everything from a company’s treatment of employees and contract labor to its potential unintended impacts on the communities in which it operates.

Research and Development 52

Research and Development Supply Chain Policy Programs 52

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 27, 2021

The Rules aim to promote social equity, safety and easy access to the cannabis marketplace while keeping local municipalities in control of how they want cannabis businesses to operate in their jurisdiction. The Rules specify different classes of licenses for each stage of the supply chain.

Cultivation 105

Cultivation Conditions Business Cannabis 105

CannaMD

APRIL 15, 2020

To learn more about medical marijuana treatment center (MMTC) delivery services, please see: Florida Dispensaries: COVID-19 Policies. To stay up-to-date with the latest studies and legal regulations surrounding medical marijuana treatment, be sure to follow CannaMD on Facebook and sign up for our newsletter, below! Get Started.

Policy 55

Policy Patients Dispensary Banking 55

Cannabis Law Report

SEPTEMBER 3, 2019

The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Global Supply Chain Platform. MediPharm Labs Australia is expected to serve as part of MediPharm Labs’ global supply chain platform and a springboard to serving the Asia-Pacific region.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

AUGUST 19, 2019

To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. Further, entities in the CBPM’s supply chain must be licensed by the Home Office and MHRA. The Regulations define a CBPM as a preparation or product that. (a)

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Cannabis Law Report

JULY 28, 2021

Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

MARCH 6, 2020

Europe is on the forefront of pharmaceutical development in the growing market for cannabinoid receptor target therapeutics which should bring further attention to our efforts in moving KLS-13019 forward for the treatment of neuropathic pain and other CNS disorders associated with neuroinflammation,” said Dean Petkanas , CEO of Kannalife.

Research and Development 59

Research and Development Marijuana Pharmaceutical Supply Chain 59

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. The FOIA case was settled at the end of April of this year.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

The Cannigma

FEBRUARY 3, 2022

MB: Right and it was a safety consideration and it’s seemed like a good idea. In some ways, I’d like to see Florida’s real treatment of this more like medicine to be played out but I just don’t think the trick is THC limits. Let’s do seed to sale, so you must grow your cannabis, harvest it, process it, and then sell it in a retail.

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

JULY 15, 2022

Federal Member for Fairfax Ted O’Brien said strict controls of the supply chain would be critical to the Government’s aspirations to make Australia the number one world player in medicinal cannabis. But bottlenecks remain to doctors prescribing the controversial treatment. ABC Rural: Jennifer Nichols ). .

Medicine 52

Medicine Patients Media Supply Chain 52

The Cannigma

JANUARY 19, 2022

The resulting prejudice can often discourage folks from seeking out medical cannabis as an option, and can even affect state legislature, forcing patients to overcome unnecessary and prohibitive obstacles in order to receive the treatment they need. CP: Ah, looking out for patients and consumers I see again ASA, that’s great.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

SEPTEMBER 22, 2019

The cannabis industry is embracing new technologies like facial recognition and advanced video analytics throughout the supply chain—from grow rooms and processing facilities to distribution centers and retail dispensaries. This may sound like a scene from a sci-fi movie, but these tools are employed in cannabis dispensaries today.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

SEPTEMBER 16, 2019

If the ruling stands, it could force the appropriate state officials to lift existing caps on how many medical marijuana treatment centers can operate in Florida. The July 9 ruling by the 1st District Court of Appeal in Tallahassee was another setback for Florida officials trying to regulate the burgeoning marijuana industry more tightly.

Policy 63

Policy Legislation Research and Development Business 63

SpeedWeed

JULY 17, 2021

Supply chains will become more efficient and cost-effective as plants would be grown in appropriate outdoor climates and other materials could be sourced across markets. Cannabis worker safety and apprenticeships must be a top priority and any federal legislation needs to dedicate funding to further research for these priorities.

Legalization 52

Legalization Banking Legislation Cannabis 52

SpeedWeed

JULY 17, 2021

Supply chains will become more efficient and cost-effective as plants would be grown in appropriate outdoor climates and other materials could be sourced across markets. Cannabis worker safety and apprenticeships must be a top priority and any federal legislation needs to dedicate funding to further research for these priorities.

Banking 52

Banking Legislation Cannabis Policy 52

SpeedWeed

JULY 16, 2021

Supply chains will become more efficient and cost-effective as plants would be grown in appropriate outdoor climates and other materials could be sourced across markets. Cannabis worker safety and apprenticeships must be a top priority and any federal legislation needs to dedicate funding to further research for these priorities.

Dispensary 52

Dispensary Banking Legislation Cannabis 52

Cannabis Law Report

MAY 14, 2022

Senator Patty Murray (D-WA) is currently leading a push to include it in a sweeping package intended to help resolve the country’s ongoing supply chain issues. This is one of the latest studies providing evidence supporting the effectiveness of medical cannabis as a treatment for such mental health issues. Dentons Speaks.

Banking 52

Banking Recreational Research and Development Cannabis 52